Cabot Corporation (NYSE:CBT) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Cabot Corporation (NYSE:CBTGet Free Report) have been assigned a consensus recommendation of “Hold” from the six research firms that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $73.75.

A number of research analysts have recently commented on the company. Mizuho set a $75.00 price objective on Cabot and gave the company a “neutral” rating in a report on Wednesday, February 4th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a report on Monday, December 29th. Jefferies Financial Group reiterated a “buy” rating and issued a $85.00 price objective on shares of Cabot in a report on Wednesday, February 4th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Finally, UBS Group increased their price objective on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a report on Thursday, February 5th.

Get Our Latest Stock Analysis on Cabot

Cabot Trading Down 2.2%

CBT opened at $74.70 on Friday. Cabot has a one year low of $58.33 and a one year high of $83.71. The company has a market cap of $3.90 billion, a P/E ratio of 13.08, a PEG ratio of 10.07 and a beta of 0.84. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.09 and a current ratio of 1.67. The business’s 50-day simple moving average is $73.50 and its 200-day simple moving average is $70.10.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings data on Tuesday, February 3rd. The specialty chemicals company reported $1.53 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.13. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The business had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. During the same quarter in the prior year, the business posted $1.76 EPS. The business’s revenue for the quarter was down 11.1% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. As a group, equities research analysts expect that Cabot will post 7.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the company. Public Employees Retirement System of Ohio grew its stake in Cabot by 15.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,202 shares of the specialty chemicals company’s stock worth $80,000 after buying an additional 160 shares during the last quarter. Janney Montgomery Scott LLC grew its stake in Cabot by 2.6% during the 4th quarter. Janney Montgomery Scott LLC now owns 6,298 shares of the specialty chemicals company’s stock worth $417,000 after buying an additional 161 shares during the last quarter. Farther Finance Advisors LLC grew its stake in Cabot by 9.6% during the 4th quarter. Farther Finance Advisors LLC now owns 1,873 shares of the specialty chemicals company’s stock worth $124,000 after buying an additional 164 shares during the last quarter. Gabelli Funds LLC grew its stake in Cabot by 1.3% during the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after buying an additional 180 shares during the last quarter. Finally, First Citizens Bank & Trust Co. grew its stake in Cabot by 1.4% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock worth $1,107,000 after buying an additional 206 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Further Reading

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.